MEDNORAL PHARMACEUTICAL LTD — Erythromycin Importer Profile
Pharmaceutical Importer · #17 buyer for Erythromycin · $359.2K import value · 12 shipments · NIGERIA · DGFT Verified
MEDNORAL PHARMACEUTICAL LTD is the #17 importer of Erythromycin from India with $359.2K in import value and 12 verified shipments. MEDNORAL PHARMACEUTICAL LTD holds a 0.5% market share in Erythromycin imports based in NIGERIA. The company sources from 1 verified supplier across 8 formulations shipped to 1 country.
MEDNORAL PHARMACEUTICAL LTD — Erythromycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Erythromycin to MEDNORAL PHARMACEUTICAL LTD?
Verified from 12 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALLIAANCE BIOTECH | $359.2K | 12 | 100.0% |
MEDNORAL PHARMACEUTICAL LTD sources Erythromycin from 1 verified Indian supplier based on 12 customs records. The primary supplier is ALLIAANCE BIOTECH accounting for 100.0% of imports.
How Does MEDNORAL PHARMACEUTICAL LTD Compare to Nearest Erythromycin Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | NOUMED LIFE SCIENCES LIMITED | UNITED KINGDOM | $474.9K | 12 | $39.6K |
| 2 | NELPA LIFESCIENCES INC | PHILIPPINES | $450.0K | 9 | $50.0K |
| 17 | MEDNORAL PHARMACEUTICAL LTD ★ | NIGERIA | $411.6K | 12 | $34.3K |
| 1 | UNICEF KABUL | AFGHANISTAN | $300.0K | 6 | $50.0K |
| 3 | GENERICS & SPECIALITIES LDA ,VALE D | MOZAMBIQUE | $300.0K | 6 | $50.0K |
MEDNORAL PHARMACEUTICAL LTD ranks #17 among 992 Erythromycin importers from India. Average shipment value of $34.3K compared to the market average of $8.6K. The closest competitors by value are NOUMED LIFE SCIENCES LIMITED and NELPA LIFESCIENCES INC.
Where Does MEDNORAL PHARMACEUTICAL LTD Import Erythromycin To?
Destination countries from 12 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $359.2K | 12 | 100.0% |
MEDNORAL PHARMACEUTICAL LTD imports Erythromycin to 1 country. The primary destination is NIGERIA receiving 100.0% of shipments worth $359.2K.
What Erythromycin Formulations Does MEDNORAL PHARMACEUTICAL LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| ERYTHROMYCIN TABLETS BP 500MG ERYMED 500 | $151.7K | 5 |
| PHARMACEUTICALS GOODS- ERYTHROMYCIN TABLETS BP 500 MG ERYMED 500 TABLET (341X36X10X1X10) BATCH NO :ATE-827 | $37.2K | 1 |
| PHARMACEUTICALS GOODS- ERYTHROMYCIN TABLETS BP 500 MG ERYMED 500 TABLET (340X36X10X1X10) BATCH NO :ATE-172 | $35.0K | 1 |
| PHARMACEUTICALS GOODS- ERYTHROMYCIN TABLETS BP 500 MG ERYMED 500 TABLET (305X36X10X1X10) BATCH NO :ATE-820 | $33.2K | 1 |
| PHARMACEUTICALS GOODS- ERYTHROMYCIN TABLETS BP 500 MG ERYMED 500 TAB.(304X36X10X1X10 B. NO :ATE-739 | $33.1K | 1 |
| PHARMACEUTICALS GOODS- ERYTHROMYCIN TABLETS BP 500 MG ERYMED 500 TABLET (305X36X10X1X10) BATCH NO :ATE-170 | $31.4K | 1 |
| PHARMACEUTICALS GOODS-ERYTHROMYCIN TABLETS BP 500 MG ERYMED 500 TABLET (305X36X10X1X10) BATCH NO :ATE-171 | $31.4K | 1 |
| ERYTHROMYCIN TABLETS BP 500 MGERYMED 500 | $6.2K | 1 |
MEDNORAL PHARMACEUTICAL LTD imports 8 distinct Erythromycin formulations from India. The top formulation is ERYTHROMYCIN TABLETS BP 500MG ERYMED 500 with 5 shipments worth $151.7K.
Regulatory Requirements: Importing Erythromycin into Nigeria
What MEDNORAL PHARMACEUTICAL LTD and other importers must comply with to import Erythromycin from India
Regulatory Authority
National Agency for Food and Drug Administration and Control (NAFDAC)
Approval Process for Generic Erythromycin
Drug registration under NAFDAC guidelines. Requires quality data, stability studies, and WHO-type Certificate of Pharmaceutical Product (CPP) from India.
Typical timeline: 6–18 months
GMP Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Import Licence & Documentation
NAFDAC import permit; Certificate of Pharmaceutical Product (CPP) from CDSCO India
Labeling & Packaging
English language labeling; NAFDAC registration number required
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified inspections of Indian sites in recent years.
Regulatory information is provided for general reference based on publicly available NAFDAC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with NAFDAC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Erythromycin from India and How Much Does MEDNORAL PHARMACEUTICAL LTD Import?
India exported $8.5M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. MEDNORAL PHARMACEUTICAL LTD imports $359.2K of this total, accounting for 0.5% of India's Erythromycin exports with 12 shipments from NIGERIA. This is verified from 12 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for MEDNORAL PHARMACEUTICAL LTD's Erythromycin Imports?
MEDNORAL PHARMACEUTICAL LTD's average Erythromycin order value is $29.9K per consignment, based on 12 shipments totaling $359.2K. MEDNORAL PHARMACEUTICAL LTD is based in NIGERIA and ranks #17 among all Erythromycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Erythromycin to MEDNORAL PHARMACEUTICAL LTD?
MEDNORAL PHARMACEUTICAL LTD sources Erythromycin from 1 verified Indian supplier: ALLIAANCE BIOTECH ($359.2K, 100.0%). This is based on 12 customs records.
How Does MEDNORAL PHARMACEUTICAL LTD Compare to Other Erythromycin Importers?
MEDNORAL PHARMACEUTICAL LTD ranks #17 among 992 Erythromycin importers from India with a 0.5% market share. The top 3 importers are ACE HEALTH CARE LDA ($1.2M), MYLAN AUSTRALIA PTY LIMITED ($1.1M), LIFESCIENCE LOGISTICS ($989.1K). MEDNORAL PHARMACEUTICAL LTD processed 12 shipments from NIGERIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MEDNORAL PHARMACEUTICAL LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MEDNORAL PHARMACEUTICAL LTD's capped import value divided by total capped export value for Erythromycin across all Indian exporters.
- 5.Verified Records: This page is backed by 12 individual customs records matching MEDNORAL PHARMACEUTICAL LTD importing Erythromycin, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Import Data for MEDNORAL PHARMACEUTICAL LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for MEDNORAL PHARMACEUTICAL LTD's Erythromycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MEDNORAL PHARMACEUTICAL LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
MEDNORAL PHARMACEUTICAL LTD × Erythromycin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MEDNORAL PHARMACEUTICAL LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current order-level data, contact TransData Nexus.